This paper is only available as a PDF. To read, Please Download here.
The surface engagement of high affinity immunoglobulin E receptor (Fc epsilon RI) of rat basophilic leukemia 2H3 (RBL-2H3) cells induced histamine secretion and leukotriene release following activation of the tyrosine kinase Lyn together with phosphatidylinositol 3-kinase (PI3-kinase). Wortmannin inhibited the activity of partially purified PI3-kinase from calf thymus, as well as the PI3-kinase activity in anti-PI3-kinase p85 immunoprecipitates from RBL-2H3 cells, at a concentration as low as 1.0 nM and with IC50 values of 3.0 nM, but did not inhibit PI4-kinase activity. The inhibition of PI3-kinase by wortmannin was irreversible. Wortmannin inhibited both Fc epsilon RI-mediated histamine secretion and leukotriene release up to 80% with IC50 values of 2.0 and 3.0 nM, respectively. Wortmannin inhibited PI3-kinase activity in intact cells up to 80% with an IC50 value of 2.0 nM, which is almost equal to those for PI3-kinase in vitro and for histamine secretion and leukotriene release. With anti-wortmannin antibody, we have shown that wortmannin binds to the 110-kDa protein, but not to PI3-kinase 85-kDa regulatory subunit both in vitro and in whole cells. Furthermore, there was a positive correlation between the potencies of wortmannin derivatives as inhibitors of PI3-kinase and as inhibitors of histamine secretion. Wortmannin had no effect on the activation of the tyrosine kinase Lyn. These results suggest that PI3-kinase is involved in the signal transduction pathway responsible for histamine secretion following stimulation of Fc epsilon RI and that wortmannin blocks these responses through direct interaction with the catalytic subunit of this enzyme.
REFERENCES
- Appl. Environ. Microbiol. 1988; 54: 1268-1274
- J. Immunol. 1992; 148: 2194-2200
- Cancer Cell. 1991; 3: 263-270
- Cell. 1989; 57: 167-175
- EMBO J. 1992; 11: 3469-3479
- J. Biol. Chem. 1993; 268: 8204-8212
- Exp. Cell Res. 1987; 169: 408-418
- J. Biol. Chem. 1984; 259: 7129-7136
- J. Biol. Chem. 1984; 259: 7137-7142
- Br. J. Pharmacol. 1991; 103: 1237-1241
- Trans. Br. Mycol. Soc. 1957; 40: 365-368
- Cell. 1991; 64: 281-302
- Biochemistry. 1990; 29: 11147-11156
- Science. 1989; 243: 1191-1194
- Biochem. Biophys. Res. Commun. 1980; 93: 42-49
- J. Immunol. 1989; 143: 2617-2625
- J. Biol. Chem. 1988; 263: 16179-16184
- Nature. 1992; 355: 78-80
- J. Biol. Chem. 1990; 265: 396-400
- Cell. 1991; 65: 75-82
- Oncogene Res. 1989; 4: 283-292
- Oncogne. 1991; 6: 407-411
- J. Immunol. 1992; 148: 2012-2022
- Immunotoxicology. 1989; 11: 559-570
- Helv. Chim. Acta. 1975; 58: 1620-1628
- J. Biol. Chem. 1992; 267: 17078-17081
- Immunology. 1987; 60: 573-578
- Mol. Cell. Biol. 1991; 11: 134-142
- Cell. 1992; 70: 419-429
- Reeves W.G. Immunology and Medicine Series; Mast Cells, Mediators and Disease. Kluwer Academic Publishers, London1988: 129-174
- EMBO J. 1990; 9: 3279-3286
- J. Biol. Chem. 1992; 267: 3423-3428
- Biochem. Biophys. Res. Commun. 1992; 183: 48-54
- Eur. J. Immunol. 1991; 21: 881-885
- J. Biol. Chem. 1990; 265: 5345-5348
- Mol. Cell. Biol. 1992; 12: 3176-3182
- J. Biol. Chem. 1989; 264: 12492-12501
- J. Chem. Soc. Perkin Trans. 1972; 1: 2898-2903
- J. Biol. Chem. 1986; 261: 2583-2592
- Annu. Rev. Immunol. 1986; 4: 419-470
- Methods Enzymol. 1992; 209: 202-211
- J. Immunol. Methods. 1983; 65: 55-63
- J. Biol. Chem. 1992; 267: 2157-2163
- Biochem. Biophys. Res. Commun. 1992; 185: 1016-1021
- Neuron. 1992; 9: 769-777
- Seikagaku. 1992; 64 (abstr): 1040
- Cell. 1991; 65: 91-104
- J. Biol. Chem. 1993; 268: 1749-1758
- J. Biol. Chem. 1993; 268: 2280-2283
- J. Biol. Chem. 1991; 266: 24237-24240
- FASEB J. 1990; 4: 208-214
- Proc. Natl. Acad. Sci. U. S. A. 1990; 87: 1411-1415
- J. Exp. Med. 1978; 147: 352-368
- Int. Immunol. 1992; 4: 447-453
- Science. 1993; 260: 88-91
- Mol. Cell. Biol. 1990; 10: 801-809
- J. Biol. Chem. 1991; 266: 8108-8114
- Anal. Biochem. 1990; 188: 416-421
- Nature. 1978; 275: 329-331
- Cell. 1991; 65: 83-90
- Mol. Immunol. 1989; 26: 641-648
- Trends Pharmacol. Sci. 1991; 121: 404-408
- Nature. 1988; 334: 353-356
- J. Biol. Chem. 1989; 264: 15668-15673
- Nature. 1989; 342: 699-702
- Mol. Cell. Biol. 1991; 11: 1107-1113
- J. Immunol. 1987; 139: 161-165
- Nature. 1985; 315: 239-242
- Biochem. J. 1987; 247: 165-174
- Experientia. 1974; 30: 135-136
- J. Immunol. 1992; 149: 1031-1037
- J. Biol. Chem. 1988; 263: 17555-17560
- Science. 1990; 251: 192-194
- Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 1118-1122
- Biochem. J. 1992; 285: 745-751
- J. Biol. Chem. 1992; 267: 25958-25965
- Mol. Cell. Biol. 1991; 11: 3780-3785
Article Info
Identification
Copyright
© 1993 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
User License
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse
Elsevier's open access license policy

Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy